| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 10/02/1997 | CA2250576A1 Monocyte chemotactic protein-5 materials and methods |
| 10/02/1997 | CA2250361A1 Myelin oligodendrocyte glycoprotein peptides and uses thereof |
| 10/02/1997 | CA2250211A1 Colostrum food supplement |
| 10/02/1997 | CA2250166A1 Soluble divalent and multivalent heterodimeric analogs of proteins |
| 10/02/1997 | CA2250058A1 Recombinant pox virus encoding myelin protein for therapy |
| 10/02/1997 | CA2250034A1 Monoclonal antibodies which bind to tumor rejection antigen precursor melan-a, and uses thereof |
| 10/02/1997 | CA2249998A1 The use of antibodies against cd48 for the treatment of t and b cell lymphomas and leukemias |
| 10/02/1997 | CA2249455A1 Precursors of catalytic antibodies |
| 10/02/1997 | CA2249354A1 Opsonin-enhanced cells, and methods of modulating an immune response to an antigen |
| 10/02/1997 | CA2249254A1 Epidermal differentiation factor |
| 10/02/1997 | CA2249208A1 Stationary phase, stress response sigma factor from mycobacterium tuberculosis, and regulation thereof |
| 10/02/1997 | CA2248675A1 Cyclic nucleotide phosphodiesterase |
| 10/02/1997 | CA2248318A1 Growth factor htter36 |
| 10/01/1997 | EP0798002A1 Inhibition of vascular stenosis |
| 10/01/1997 | EP0797667A1 Papillomavirus vaccine |
| 10/01/1997 | EP0797660A1 Human immunodeficiency virus vaccines and therapeutics containing replication-impaired hiv-1 nef-deletion mutants |
| 10/01/1997 | EP0797587A1 Recombinant antigen for diagnosing rheumatoid arthritis |
| 10/01/1997 | EP0797586A1 NOVEL MEMBRANE PROTEINE p76 OF HELICOBACTER PYLORI |
| 10/01/1997 | EP0797585A1 Helicobacter lactoferrin receptor |
| 09/30/1997 | US5672694 β-sarcoglycan nucleic acid sequence, and nucleic acid probes |
| 09/30/1997 | US5672689 Non-cleavable GP160 glycoproteins of HIV |
| 09/30/1997 | US5672688 Immunoglobulin Fc fragment bound to an alkylating, antibiotic, or antimetabolic antitum or substance |
| 09/30/1997 | US5672687 Medical diagnosis; bone marrow transplants |
| 09/30/1997 | US5672684 Polypeptide having sequence of vp7 protein of human rotavirus serotype 4 |
| 09/30/1997 | US5672683 Nerve growth factor or ciliary neurotrophic factor bound at its amino end to the carboxyl end of a transferrin, for delivery across blood brain barrier |
| 09/30/1997 | US5672581 Drug delivery; aerosol, programmed, portable, disposable |
| 09/30/1997 | US5672513 Carcino-embryonic antigen derivatives lacking the carboxyl terminal end |
| 09/30/1997 | US5672500 Mch2, an apoptotic cysteine protease, and compositions for making and methods of using the same |
| 09/30/1997 | US5672488 Contraceptive vaccine based on alloimmunization with zona pellucida polypeptides |
| 09/30/1997 | US5672486 Protein polyligands joined to a stable protein core |
| 09/30/1997 | US5672480 Immunoassays for prostate specific antigen |
| 09/30/1997 | US5672350 Administering to elicit immune response which reduces severity of bovine coronavirus infection in mammal |
| 09/30/1997 | US5672349 Process for the expression of herpes simplex virus type 1 glycoprotein I and methods of use |
| 09/30/1997 | US5672345 Stable genetic engineered vaccines |
| 09/30/1997 | US5671848 Tagged antibodies capable of recognizing the non-variable region of the anti-heat shock protein 65 antibody to be detected |
| 09/25/1997 | WO1997035193A1 Cryptic peptides and method for their identification |
| 09/25/1997 | WO1997035021A2 Prostate specific antigen oligo-epitope peptide |
| 09/25/1997 | WO1997035019A1 Protein tyrosine phosphatases of hematopoietic cells |
| 09/25/1997 | WO1997035008A1 Methods and compositions of chimeric polypeptides for tumor antigen vaccines |
| 09/25/1997 | WO1997034921A1 Conjugated mucin peptide vaccines |
| 09/25/1997 | WO1997034911A1 Apoptosis inducing molecule ii |
| 09/25/1997 | WO1997034636A1 Humanization of an anti-carcinoembryonic antigen anti-idiotype antibody and use as a tumor vaccine and for targeting applications |
| 09/25/1997 | WO1997034635A1 Anti-idiotypic antibody vaccines |
| 09/25/1997 | WO1997034633A1 Methods for inhibiting an immune response by blocking the gp39/cd40 and ctla4/cd28/b7 pathways and compositions for use therewith |
| 09/25/1997 | WO1997034632A1 Glycosylated humanized b-cell specific antibodies |
| 09/25/1997 | WO1997034631A1 Immunoglobin-like domains with increased half lives |
| 09/25/1997 | WO1997034630A1 Peptide vaccine to prevent development of several herpes virus infections and/or atherosclerotic plaque |
| 09/25/1997 | WO1997034629A1 Immunogenic compositions comprising porphyromonas gingivalis peptides and methods |
| 09/25/1997 | WO1997034624A1 Injectable therapy for control of muscle spasms and pain related to muscle spasms |
| 09/25/1997 | WO1997034621A1 Hla-a2.1 binding peptides and their uses |
| 09/25/1997 | WO1997034617A1 Hla binding peptides and their uses |
| 09/25/1997 | WO1997034613A1 Peptides recognized by melanoma-specific a1-, a2- and a3-restricted cytotoxic lymphocytes, and uses therefor |
| 09/25/1997 | WO1997034599A2 Use of clotrimazole and related compounds in the treatment of diarrhea |
| 09/25/1997 | WO1997034586A2 Device and method for treating ophthalmic diseases |
| 09/25/1997 | WO1997034583A1 Method for inducing a systemic immune response to an antigen |
| 09/25/1997 | WO1997034472A1 Methods for inducing immune responsiveness in a subject |
| 09/25/1997 | WO1997019113A3 Monoclonal antiidiotypic antibodies (ab2) and uses thereof |
| 09/25/1997 | WO1997017446A3 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF |
| 09/25/1997 | DE19649604C1 Purification and refolding of human papilloma virus proteins extracted from cells |
| 09/25/1997 | DE19634159C1 Hybrid cells prepared by fusing malignant B cells with hybridoma that expresses antibodies |
| 09/25/1997 | CA2283633A1 Peptide vaccine to prevent development of several herpes virus infections and/or atherosclerotic plaque |
| 09/25/1997 | CA2249994A1 Immunogenic compositions comprising porphyromonas gingivalis peptides and methods |
| 09/25/1997 | CA2249412A1 Methods for inducing immune responsiveness in a subject |
| 09/25/1997 | CA2249395A1 Conjugated mucin peptide vaccines |
| 09/25/1997 | CA2249196A1 Injectable therapy for control of muscle spasms and pain related to muscle spasms |
| 09/25/1997 | CA2249195A1 Immunoglobin-like domains with increased half lives |
| 09/25/1997 | CA2248868A1 Apoptosis inducing molecule ii |
| 09/25/1997 | CA2248659A1 Hla binding peptides and their uses |
| 09/25/1997 | CA2243509A1 Anti-idiotypic antibody vaccines |
| 09/24/1997 | EP0796341A2 Identification of genes |
| 09/24/1997 | EP0796333A1 Glycoproteins from herpes virus and vaccines containing them |
| 09/24/1997 | EP0796332A1 Neisseria meningitidis subunit tbp2 |
| 09/24/1997 | EP0796331A2 Production and administration of high titer recombinant retroviruses |
| 09/24/1997 | EP0796326A1 Vaccine and antitoxin for treatment and prevention of c. difficile disease |
| 09/24/1997 | EP0796325A1 Human vascular ibp-like growth factor |
| 09/24/1997 | EP0796280A2 Murine monoclonal anti-idiotype antibody 3h1 |
| 09/24/1997 | EP0796279A1 Antigen, antibodies and diagnostic assay for alzheimer's disease |
| 09/24/1997 | EP0796277A1 Reagents and processes for targeting mutant epidermal growth factor receptors |
| 09/24/1997 | EP0796276A1 Gradual modification, super-agonists and antagonists of signal-proteins and peptides |
| 09/24/1997 | EP0796273A1 Variants of human papilloma virus antigens |
| 09/24/1997 | EP0796104A1 Delivery of nucleic acid molecules to mucosal tissue |
| 09/24/1997 | EP0521985B1 Chimeric antibodies with receptor binding ligands in place of their constant region |
| 09/24/1997 | CN1159914A Oil adjuvant vaccine and method for preparing same |
| 09/23/1997 | US5670690 Compositions and methods for removal of detergents |
| 09/23/1997 | US5670630 Expression of hepatitis B S and preS2 proteins in methylotrophic |
| 09/23/1997 | US5670626 Allergen-specific human IgA monoclonal antibodies for mucosal administration |
| 09/23/1997 | US5670617 Nucleic acid conjugates of tat-derived transport polypeptides |
| 09/23/1997 | US5670481 Dorsal tissue affecting factor (noggin) and compositions comprising same |
| 09/23/1997 | US5670370 Replicon |
| 09/23/1997 | US5670367 Recombinant fowlpox virus |
| 09/23/1997 | US5670362 DNA encoding an Eimeria 100kD antigen |
| 09/23/1997 | US5670337 Polymorphism of human platelet membrane glycoprotein IIIa and diagnostic and therapeutic applications thereof |
| 09/23/1997 | US5670311 Peptides for detecting antibodies to HTLV-2 |
| 09/23/1997 | US5670156 Viricides and immunogens |
| 09/23/1997 | US5670153 Immunoreactive polypeptide compositions |
| 09/23/1997 | US5670152 Containing hepatitis virus epitopes |
| 09/23/1997 | US5670150 Non-depleting CD4-specific monoclonal antibodies for the treatment of insulin-dependent diabetes mellitus (IDDM) |
| 09/23/1997 | US5670148 Combined cellular and immunosuppressive therapies |
| 09/23/1997 | US5670134 Method for evaluating and modifying biological activity |
| 09/23/1997 | CA1339469C Production and characteristics of anti-anti-cea antibody |